| scholarly article | Q13442814 |
| P50 | author | Eva Feldman | Q5415042 |
| P2093 | author name string | Brian C Callaghan | |
| Raymond S Price | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| Enhanced glucose control for preventing and treating diabetic neuropathy | Q24202790 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis | Q28085455 | ||
| Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990 | Q28253691 | ||
| Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial | Q28304712 | ||
| Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
| Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial | Q33903527 | ||
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial | Q34008233 | ||
| EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 | ||
| Does this patient with diabetes have large-fiber peripheral neuropathy? | Q34111140 | ||
| Duloxetine vs. placebo in patients with painful diabetic neuropathy | Q34422685 | ||
| Epidemiology of Bell's palsy in an Italian Health District: incidence and case-control study. | Q34431730 | ||
| Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology | Q34441004 | ||
| Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis | Q34445967 | ||
| A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain | Q34464747 | ||
| Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study | Q34549778 | ||
| The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. | Q34626423 | ||
| Charcot-Marie-Tooth disease subtypes and genetic testing strategies | Q34681666 | ||
| When exactly can carpal tunnel syndrome be considered work-related? | Q34692583 | ||
| Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. | Q34701739 | ||
| Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial | Q35159258 | ||
| Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. | Q35225448 | ||
| Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases | Q35506843 | ||
| Incidence of common compressive neuropathies in primary care | Q36142629 | ||
| Tests and expenditures in the initial evaluation of peripheral neuropathy | Q36959500 | ||
| Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy | Q37040153 | ||
| High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial | Q37118241 | ||
| Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts? | Q37251692 | ||
| Incidence and epidemiology of cervical radiculopathy in the United States military: 2000 to 2009. | Q37856701 | ||
| Clinical implications of genetic advances in Charcot-Marie-Tooth disease | Q38135690 | ||
| Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens | Q39366709 | ||
| Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial | Q39368431 | ||
| Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial | Q39377711 | ||
| A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics | Q39451068 | ||
| Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood | Q39538457 | ||
| ??? | Q24632313 | ||
| Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes | Q39692507 | ||
| Lifestyle intervention for pre-diabetic neuropathy | Q40321365 | ||
| Incidence of polyneuropathy in Utrecht, the Netherlands | Q41694795 | ||
| Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial | Q43073033 | ||
| Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus | Q43453964 | ||
| Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy | Q43687920 | ||
| Hypertension as a risk factor for diabetic neuropathy: a prospective study | Q43870599 | ||
| The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population | Q44353135 | ||
| The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy | Q44890977 | ||
| Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial | Q45185821 | ||
| Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. | Q46200483 | ||
| Evaluation of patients with symptoms suggestive of chronic polyneuropathy. | Q46200487 | ||
| Carpal tunnel syndrome: the association with occupation at a population level | Q47340543 | ||
| Factors associated with falls in older patients with diffuse polyneuropathy | Q47615068 | ||
| Characterization of the incidence and risk factors for the development of lumbar radiculopathy | Q47835380 | ||
| A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain | Q48389097 | ||
| Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial | Q48779182 | ||
| Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. | Q50576364 | ||
| Incidence of ulnar neuropathy at the elbow in the province of Siena (Italy). | Q50764422 | ||
| Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. | Q50971049 | ||
| Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. | Q53067530 | ||
| The epidemiology and treatment of Bell's palsy in the UK. | Q54199104 | ||
| Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers | Q58647868 | ||
| Incidence rates and determinants in meralgia paresthetica in general practice | Q60679220 | ||
| Prevalence of peripheral neuropathy in the Parsi community of Bombay | Q68248080 | ||
| Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980 | Q68251791 | ||
| Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study | Q68734871 | ||
| Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study | Q69440204 | ||
| The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study | Q70651014 | ||
| Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial | Q70799310 | ||
| Intensive evaluation of referred unclassified neuropathies yields improved diagnosis | Q70965795 | ||
| Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG) | Q71525400 | ||
| Chronic cryptogenic polyneuropathy. The search for a cause | Q71781941 | ||
| Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group | Q72391699 | ||
| Peripheral neuropathy | Q80247543 | ||
| Clinical, electrodiagnostic, and sonographic studies in ulnar neuropathy at the elbow | Q80364303 | ||
| Hospital-referred polyneuropathies--causes, prevalences, clinical- and neurophysiological findings | Q80410083 | ||
| Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, | Q82838750 | ||
| Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs | Q85899145 | ||
| The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists | Q86564283 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2172-2181 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Distal Symmetric Polyneuropathy: A Review | |
| P478 | volume | 314 |
| Q40073873 | A Case of Tetraplegia after Proteus mirabilis Infection |
| Q55057750 | A comparison of balance control during stance and gait in patients with inflammatory and non-inflammatory polyneuropathy. |
| Q55004952 | ACUDIN - ACUpuncture and laser acupuncture for treatment of DIabetic peripheral Neuropathy: a randomized, placebo-controlled, partially double-blinded trial. |
| Q51185056 | Activation of TRPM2 and TRPV1 Channels in Dorsal Root Ganglion by NADPH Oxidase and Protein Kinase C Molecular Pathways: a Patch Clamp Study. |
| Q90452403 | Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management |
| Q38770566 | Assessment scales for the diagnosis of polyneuropathy |
| Q92701255 | Association between serum uric acid and large-nerve fiber dysfunction in type 2 diabetes: a cross-sectional study |
| Q50135376 | Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. |
| Q93159371 | Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons |
| Q38921141 | Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease. |
| Q57288398 | Correlation Between Different Stages of Diabetic Nephropathy and Neuropathy in Patients with T2DM: A Cross-Sectional Controlled Study |
| Q55233269 | Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. |
| Q97646293 | Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus |
| Q92733581 | Diabetic neuropathy |
| Q33830497 | Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome. |
| Q93140817 | Effect of Short-Term Increase in Meal Frequency on Glucose Metabolism in Individuals with Normal Glucose Tolerance or Impaired Fasting Glucose: A Randomized Crossover Clinical Trial |
| Q33653891 | Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study |
| Q92132412 | Enhancing plasticity in central networks improves motor and sensory recovery after nerve damage |
| Q89138030 | Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy |
| Q38827326 | High body mass and kidney dysfunction relate to worse nerve function, even in adults without neuropathy |
| Q58874310 | How can neuroplasticity be utilized to improve neuropathy symptoms? |
| Q37074957 | Impact of neuropathy on the adherence to diabetes-related self-care activities: a cross-sectional study |
| Q36685151 | Integrating cannabis into clinical cancer care |
| Q93001584 | Longitudinal pattern of pain medication utilization in peripheral neuropathy patients |
| Q61443044 | Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes |
| Q92926085 | Painful and non-painful diabetic polyneuropathy: Clinical characteristics and diagnostic issues |
| Q57165347 | RETRACTED: A meta-analysis of surgical decompression in the treatment of diabetic peripheral neuropathy |
| Q38869328 | Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy |
| Q92459188 | The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity |
| Q50066034 | The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes |
| Q41606328 | Thermal perception thresholds among workers in a cold climate. |
| Q64967487 | Time to Onset of Paresthesia Among Community Members Exposed to the World Trade Center Disaster. |
| Q64095060 | Timed Vibration Sense and Joint Position Sense Testing in the Diagnosis of Distal Sensory Polyneuropathy |
| Q52650664 | Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story. |
Search more.